LYEL - Lyell Immunopharma EPS beats by $49.14 beats on revenue November, 12 2021 08:53 AM Lyell Immunopharma Inc. Lyell Immunopharma (NASDAQ:LYEL): Q3 Net Loss of $48.87M Revenue of $2.75M (+157.0% Y/Y) beats by $0.45M. Press Release For further details see: Lyell Immunopharma EPS beats by $49.14, beats on revenue